Share This
AMHERST, Mass. – The Massachusetts Department of Public Health (DPH) and the University of Massachusetts continue to gather data on the prevalence and incidence of COVID-19 in the state. As a response to improving COVID rates, the study is shifting focus toward the study of antibody prevalence, as well as COVID infections in the general population.
Image
The state DPH is the study’s sponsor. “This effort will help us understand the actual effect of infection and vaccination in Massachusetts,” said Monina Klevens, director of research and evaluation for the Bureau of Infectious Disease and Laboratory Sciences at DPH.
UMass team identifies cancer research breakthrough
Updated May 06, 2021;
Posted May 06, 2021
The University of Massachusetts Amherst Institute for Applied Life Sciences has been a home for research into the treatment of cancer and other diseases, where scientists say they are making a breakthrough. (JIM KINNEY/ THE REPUBLICAN)
Facebook Share
A team of University of Massachusetts Amherst researchers has announced the engineering of a tiny particle it says has the potential to revolutionize disease treatment, including for cancer.
The new research combines two different approaches to more precisely and effectively deliver treatment to the specific cells affected by cancer. The work has been ongoing at the UMass Amherst Institute for Applied Life Sciences, where researchers say a nanoparticle has far-reaching potential.
The
Get Back Massachusetts COVID-19 Testing Project is a collaboration to get an accurate count of individuals infected with COVID-19 over time. The Get Back Mass project will survey and test all randomly selected participants, including those who do not have symptoms. The project will use two home-collected tests: one to test for current COVID-19 infection; and one to test for past COVID-19 infection or vaccination (antibody test). The results will improve our understanding of how COVID-19 has spread across Massachusetts and which communities and populations are most affected. The project aims to enroll about 500 Massachusetts residents per month and will run for about 14-months.